Publicaciones (25) Publicaciones de JULIO CONTRERAS RODRÍGUEZ

2022

  1. Bases genéticas, moleculares y bioquímicas del envejecimiento auditivo ¿Qué nos enseñan los modelos experimentales

    AUDITIO, Vol. 0, Núm. 6

2021

  1. Therapeutic efficiency of the APAF-1 antagonist LPT99 in a rat model of cisplatin-induced hearing loss

    Clinical and Translational Medicine

2017

  1. A comparative study of drug delivery methods targeted to the mouse inner ear: Bullostomy Versus transtympanic injection

    Journal of Visualized Experiments, Vol. 2017, Núm. 121

2016

  1. Erratum to IGF-1 deficiency causes atrophic changes associated with upregulation of VGluT1 and downregulation of MEF2 transcription factors in the mouse cochlear nuclei (Brain Struct Funct, (2016), 10.1007/s00429-014-0934-2)

    Brain Structure and Function

  2. IGF-1 deficiency causes atrophic changes associated with upregulation of VGluT1 and downregulation of MEF2 transcription factors in the mouse cochlear nuclei

    Brain Structure and Function, Vol. 221, Núm. 2, pp. 709-734

2015

  1. Comparative gene expression study of the vestibular organ of the Igf1 deficient mouse using whole-transcript arrays

    Hearing Research, Vol. 330, pp. 62-77

  2. Corrigendum to Swept-sine noise-induced damage as a hearing loss model for preclinical assays [Frontiers in Neuroscience, (2015)]

    Frontiers in Aging Neuroscience

  3. Corrigendum to Transforming growth factor β1 inhibition protects from noise-induced hearing loss [Front. Aging Neurosci., 7, (2015), 72]

    Frontiers in Aging Neuroscience

  4. Swept-sine noise-induced damage as a hearing loss model for preclinical assays

    Frontiers in Aging Neuroscience, Vol. 7, Núm. FEB

  5. Transforming growth factor β1 inhibition protects from noise-induced hearing loss

    Frontiers in Aging Neuroscience, Vol. 7, Núm. FEB

2014

  1. Early Development of the Vertebrate Inner Ear

    Development of Auditory and Vestibular Systems: Fourth Edition (Elsevier Inc.), pp. 1-30

2013

  1. IGF-I deficiency and hearing loss: molecular clues and clinical implications.

    Pediatric endocrinology reviews : PER, Vol. 10, Núm. 4, pp. 460-472

  2. XProgrammed cell senescence during mammalian embryonic development

    Cell, Vol. 155, Núm. 5, pp. 1104

2012

  1. Early Development of the Vertebrate Inner Ear

    Anatomical Record, Vol. 295, Núm. 11, pp. 1775-1790

2010

  1. A comparative study of age-related hearing loss in wild type and insulin-like growth factor I deficient mice

    Frontiers in Neuroanatomy

  2. Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice

    Laboratory Animals, Vol. 44, Núm. 2, pp. 124-131

  3. Melanin precursors prevent premature age-related and noise-induced hearing loss in albino mice

    Pigment Cell and Melanoma Research, Vol. 23, Núm. 1, pp. 72-83

2006

  1. Neurobiología de la audición: ¿qué podemos aprender en el laboratorio?

    FIAPAS: Confederación Española de Familias de Personas Sordas, Núm. 111, pp. 1-7

  2. Sensorineural hearing loss in insulin-like growth factor I-null mice: A new model of human deafness

    European Journal of Neuroscience, Vol. 23, Núm. 2, pp. 587-590

2005

  1. Double bouquet cell in the human cerebral cortex and a comparison with other mammals

    Journal of Comparative Neurology, Vol. 486, Núm. 4, pp. 344-360